Balancing Costs, Access, and Innovation in Wound Healing: A Logical Approach? #CAMPs #ActAgainstAmputation
Summary: In a critical commentary on the DF Blog at DiabeticFootOnline, David G. Armstrong reflects on recent CMS reform proposals targeting reimbursement for cellular and acellular products (CAMPs). Citing new research led by Bill Tettelbach (published in the Journal of Wound Care), the piece argues that blunt reimbursement cuts risk increasing inequity, threatening innovation, and harming vulnerable patients.
Key Highlights:
- In 2023, just 3% of nonfacility providers accounted for nearly 64% of Medicare’s CAMP spending, with average per-patient costs dramatically higher than typical providers.
- While aiming to limit waste and fraud, flat-rate reimbursement models risk penalizing ethical, resource-limited, or rural providers—limiting patient access to life-saving therapies.
- Dramatic reductions in CAMP availability could lead to higher downstream costs through more amputations, hospitalizations, and poorer outcomes.
- Policy proposals include smarter, AI-assisted oversight, targeted intervention on high-use providers, equitable reimbursement tied to clinical complexity, and sustained support for innovation and vulnerable care settings.
Read the full post on DF Blog (DiabeticFootOnline)
Keywords:
CMS reform,
CAMPs,
wound healing innovation,
health equity,
David G. Armstrong,
Bill Tettelbach